Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
48 /100
MEDIUM RISK
Score updated Jul 28, 2026

VANI — Vivani Medical, Inc. Dilution Risk Tracker

Track VANI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VANI — Get alerts when the score changes →

As of July 28, 2026, Vivani Medical, Inc. (VANI) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Vivani Medical, Inc. has a market capitalization of $113.83M, 86.24M shares outstanding, 45 institutional holders tracked. Key dilution vectors include 927.2K outstanding warrants, approximately 10 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄Convertible Debt

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
🔄 Reverse Split 40%
• 50-day avg $1.20 approaching $1 threshold
• 10 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (10mo)
🔔 Track VANI — Get forecast alerts →

Market Data

Market Cap$113.83M
Shares Outstanding86.24M
Float38.86M
Cash$19.75M
Debt$2.20M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 31.3% shares (2026Q1 vs prior)
45 institutional holders · 7.25M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 3.06M shares
#2 Tanager Wealth Management LLP 641.1K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 600.6K shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest354.4K
Days to Cover1.0
% of Float0.9%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-12-31
xbrl XBRL CONVERTIBLE 2016-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for VANI Shareholders

Vivani Medical, Inc. (VANI) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

DilutionWatch tracks 927,152 outstanding warrants for VANI. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: VANI has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for VANI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for VANI alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →

Understanding VANI's Dilution Risk Factors

Primary Risk Drivers

The two most concerning factors in Vivani Medical’s dilution profile are Offering Ability and Cash Runway. Offering Ability scores at a moderate level, indicating the company has the capacity to raise capital through equity offerings, which can lead to share issuance and dilution of existing ownership. Cash Runway is also elevated, signaling that the company's cash reserves are limited and nearing depletion, which may prompt urgency in seeking new funding sources. This combination suggests that if the company needs to raise money soon, it could issue new shares at a discount or through rights offerings, directly impacting current shareholders.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently low, indicating minimal risk from large block sales or warrant conversions. However, any significant increase in the number of shares available for trading or a spike in warrant exercises could quickly raise these scores. For Float Risk to become concerning, there would need to be a major change such as a large secondary offering or a reverse stock split that increases float. Warrant Exposure could rise if the company issues new warrants with lower strike prices or if existing warrants are exercised en masse.

SEC Filings to Watch

Several filings carry significant implications for VANI’s dilution risk. An S-3 registration statement signals a potential large-scale equity offering, which could dramatically increase share count. A 424B5 filing may indicate a planned rights offering or distribution of new securities. An 8-K Item 1.01 event would notify investors of a material event such as a new financing or issuance of shares. Additionally, a 10-Q filing that shows declining cash reserves or increased debt could imply the company is in need of capital, increasing dilution risk.

How Dilution Happens

Dilution occurs when new shares are issued, reducing the ownership percentage of existing shareholders. If VANI's Offering Ability score increases, it may lead to a new equity offering where the company issues additional shares at a price below market value. This directly dilutes current shareholders' stakes. Similarly, if Cash Runway deteriorates and the company needs capital urgently, it might issue convertible notes or warrants that convert into common stock, further increasing the total number of shares outstanding and reducing each shareholder’s proportionate interest.

What Would Make This Worse

A significant worsening of VANI's risk profile would occur if the company initiates a large equity offering while simultaneously issuing convertible notes or warrants with low strike prices. If Cash Runway drops below six months and the company begins frequent capital raises, it could lead to rapid dilution. Additionally, any major change in board composition or executive turnover that signals financial distress could trigger increased issuance activity, further exacerbating the dilution risk.

Key Insight

While low scores are safer, VANI’s elevated Offering Ability and Cash Runway scores suggest a growing need for capital that could result in share issuance and dilution of current holdings.

How to Monitor VANI for Dilution Risk

What This Risk Level Means

For a micro-cap operating company like Vivani Medical, Inc., a medium dilution risk score indicates that while the company is not currently in immediate danger of excessive dilution, it does carry a moderate exposure to potential dilutive events. In this context, "medium" suggests that the company’s capital structure and financing activities are under scrutiny but have not yet reached a point where aggressive dilution tactics are likely. Given the company's small market capitalization and operating nature, any significant issuance of new shares or conversion of debt into equity could dramatically impact existing shareholders. The risk is not immediate, but it warrants careful monitoring due to the inherent vulnerabilities of smaller companies with limited financial buffers.

What Typically Happens Next

Companies at this profile often proceed through a series of capital-raising activities that may include shelf registrations or ATM programs to fund operations or strategic initiatives. In some cases, warrant exercises or convertible note conversions are used to raise capital without immediate dilution impact, but these can quickly escalate if the company enters a phase of rapid growth or financial stress. The typical timeframe for such events is anywhere from 6 months to 2 years, depending on the company’s cash runway and strategic decisions. Shelf & ATM Monitor tracks these patterns closely and can help identify when a company is preparing for or executing capital raises that could affect shareholder value.

Monitoring Playbook

To monitor VANI effectively, use DilutionWatch to track changes in key dilution factors such as Offering Ability and Cash Runway. Set alerts when any of these scores rise above 50/100, particularly if multiple factors are increasing simultaneously. Check the company’s SEC filings monthly for new equity offerings or convertible debt announcements. When thresholds are hit, review recent press releases, earnings calls, and financial statements to assess whether the company is raising capital or restructuring debt. A proactive approach ensures early detection of dilution threats before they significantly impact shareholder value.

Early Warning Signals

Three key warning signals to watch for include: 1) A sudden increase in Offering Ability score, indicating a higher likelihood of new share issuance; 2) An upward trend in Cash Runway, suggesting the company may be nearing a point where it must raise capital urgently; and 3) A marked rise in Convertible Note Risk, which could signal an impending conversion event that dilutes existing shareholders. These changes often appear in SEC filings or are reflected in updated DilutionWatch scores.

What a Positive Resolution Looks Like

A positive resolution would involve the company completing a capital raise that improves its cash runway, reducing reliance on potentially dilutive financing. Alternatively, a debt paydown or expiry of warrants could reduce future dilution pressure. Additionally, if the company enters a phase where it no longer needs to issue new equity and begins generating consistent cash flow, the DilutionWatch scores would likely decline. These improvements signal a stronger financial position and reduced risk of further dilution.

Watch For

Any increase in Offering Ability or Convertible Note Risk scores above 50/100, as these are early indicators of potential capital-raising activity.

Full SEC filing analysis available with free account  →
Track VANI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VANI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VANI
VANI FDA Catalyst Timeline & Biotech Grade — BiotechSignsVANI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.